Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Swiss Medical Weekly|September 6, 2017
Acute aortic dissection: pathogenesis, risk factors and diagnosisJoanna Gawinecka, Felix Schönrath, Arnold von Eckardstein
Swiss Medical Weekly|April 10, 2026
Bilirubin interference in creatinine assays: cross-sectional analysis of the impact on the MELD score and CKD staging using Jaffe vs enzymatic methodsKathrin Frey, Joanna Gawinecka, Arnold Von Eckardstein, et al.
Clinical Chemistry and Laboratory Medicine|May 14, 2024
Comparison of a two-step Tempus600 hub solution single-tube vs. container-based, one-step pneumatic transport systemMarc Luginbühl, Kathrin Frey, Joanna Gawinecka, et al.
European Archives of Psychiatry and Clinical Neuroscience|August 8, 2018
Cerebrospinal fluid markers analysis in the differential diagnosis of dementia with Lewy bodies and Parkinson's disease dementiaKarin Gmitterová, Joanna Gawinecka, Franc Llorens, et al.
Clinical Chemistry and Laboratory Medicine|December 20, 2017
Rule-out of non-ST elevation myocardial infarction by five point of care cardiac troponin assays according to the 0 h/3 h algorithm of the European Society of CardiologyDurie Suh, Dagmar I Keller, Danielle Hof, et al.
Neuro-Degenerative Diseases|January 4, 2012
Desmoplakin as a potential candidate for cerebrospinal fluid marker to rule out 14-3-3 false positive rates in sporadic Creutzfeldt-Jakob disease differential diagnosisJoanna Gawinecka, Barbara Ciesielczyk, Pascual Sanchez-Juan, et al.
Acta Neurologica Belgica|December 7, 2011
Sporadic CJD in a patient with relaplsing-remitting multiple sclerosis on an immunomodulatory treatmentTereza Gabelić, Mario Habek, Inga Zerr, et al.
Journal of Neuropathology and Experimental Neurology|July 18, 2013
Filtration of protein aggregates increases the accuracy for diagnosing prion diseases in brain biopsiesWiebke M Wemheuer, Arne Wrede, Joanna Gawinecka, et al.
Atherosclerosis|December 27, 2021
Elevated levels of apolipoprotein D predict poor outcome in patients with suspected or established coronary artery diseaseWijtske Annema, Joanna Gawinecka, Axel Muendlein, et al.
Frontiers in Pharmacology|February 5, 2026
Dulaglutide and pregnancy: a comprehensive safety assessment using the ex vivo placenta perfusion and in vitro modelsSabrina Kuoni, Sara Caviglia, Alexandra Dolder, et al.
Pageof 4